CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY
Coronary Aneurysms After Drug-Eluting Stent ImplantationClinical, Angiographic, and Intravascular Ultrasound Findings
Fernando Alfonso, MD*,
Maria-José Pérez-Vizcayno, MD,
Miguel Ruiz, MD,
Alfonso Suárez, MD,
Miguel Cazares, MD,
Rosana Hernández, MD,
Javier Escaned, MD,
Camino Bañuelos, MD,
Pilar Jiménez-Quevedo, MD and
Carlos Macaya, MD
Interventional Cardiology Unit, Cardiovascular Institute, Clínico San Carlos University Hospital, Madrid, Spain
Manuscript received August 11, 2008;
revised manuscript received January 6, 2009,
accepted January 12, 2009.
* Reprint requests and correspondence: Dr. Fernando Alfonso, Cardiología Intervencionista, Instituto Cardiovascular, Hospital Universitario, Clínico "San Carlos," Plaza de Cristo Rey, Madrid 28040, Spain (Email: falf{at}hotmail.com).
Objectives: This study sought to assess clinical, angiographic, and intravascular ultrasound (IVUS) findings in patients developing coronary aneurysms (CANs) after drug-eluting stent (DES) implantation.
Background: The long-term safety of DES remains unsettled.
Methods: This study analyzed 1,197 consecutive patients with late angiographic evaluation after DES implantation. In 15 patients (1.25%, 95% confidence interval: 0.58 to 1.93), CANs developed at follow-up. Analyses included quantitative angiography and volumetric IVUS.
Results: DES developing CANs were more frequently implanted during acute myocardial infarction and were longer than those without this outcome. The elapsed time from DES implantation to CAN diagnosis was 313 ± 194 days. Angiographically, maximal CAN diameter measured 5.1 ± 1.2 mm. On IVUS, CAN external elastic lamina area was 32 ± 13.1 mm2 and incomplete apposition area was 12.1 ± 8.6 mm2. Two patients presented with acute myocardial infarction secondary to DES thrombosis. Four additional patients presented with unstable angina and underwent CAN aggressive dilation (3 were also treated for concomitant in-stent restenosis). Dual antiplatelet therapy was recommended in the remaining 9 patients who were asymptomatic at CAN diagnosis, but 1 of them eventually died of cardiogenic shock after a CAN-related myocardial infarction. After a mean follow-up of 399 ± 347 days, the 1-year event-free survival was 49 ± 14% and was related to CAN size on IVUS. In 2 patients, CANs disappeared at repeated late angiography and IVUS showed abluminal CAN thrombosis.
Conclusions: After DES implantation, CANs are rare and may be detected in asymptomatic patients. However, CANs are frequently associated with adverse clinical events as a result of DES restenosis and DES thrombosis. Further studies are required to determine the implications of this distinct new entity.
Key Words: coronary aneurysm • drug-eluting stents • angiography • intravascular ultrasound
|
Abbreviations and Acronyms
| | CAN = coronary aneurysm | | CI = confidence interval | | DES = drug-eluting stent(s) | | IVUS = intravascular ultrasound |
|
Related Articles
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A29.
[Full Text]
[PDF]
-
The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study: Evaluation Using Ultrasmall Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging in Carotid Disease
- Tjun Y. Tang, Simon P.S. Howarth, Sam R. Miller, Martin J. Graves, Andrew J. Patterson, Jean-Marie U-King-Im, Zhi Y. Li, Stewart R. Walsh, Andrew P. Brown, Peter J. Kirkpatrick, Elizabeth A. Warburton, Paul D. Hayes, Kevin Varty, Jonathan R. Boyle, Michael E. Gaunt, Andrew Zalewski, and Jonathan H. Gillard
J. Am. Coll. Cardiol. 2009 53: 2039-2050.
[Abstract]
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
Coronary Aneurysm After Drug-Eluting Stent Implantation
Journal Watch Cardiology,
July 15, 2009;
2009(715):
3 - 3.
[Full Text]
|
|
|
|
